Abstract:A novel and facile synthesis of quinoxalinone derivatives was developed in which a wide range of 3‐chloroquinoxalin‐2(1 H )‐ones as key intermediates can be generated chemo‐ and regioselectively in good yields from corresponding quinoxaline‐2,3(1 H ,4 H )‐diones. This new protocol is arguably superior, as it allows the design and preparation of a variety of bioactive quinoxaline‐based compounds, which are particularly effective in the treatment of diabetes and its complications. Through this procedure, a new class of quinoxalinone‐based aldose reductase inhibitors were synthesized successfully. Most of the inhibitors, with an N1‐acetic acid head group and a substituted C3‐phenoxy side chain, proved to be potent and selective. Their IC 50 values ranged from 11.4 to 74.8 n M . Among them, 2‐(3‐(4‐bromophenoxy)‐7‐fluoro‐2‐oxoquinoxalin‐1(2 H )‐yl)acetic acid and 2‐(6‐bromo‐3‐(4‐bromophenoxy)‐2‐oxoquinoxalin‐1(2 H )‐yl)acetic acid were the most active. Structure–activity relationship and molecular docking studies highlighted the importance of the ether spacer in the C3‐phenoxy side chains, and provided clear guidance on the contribution of substitutions both at the core structure and the side chain to activity.

Structure-Activity Relationships Studies of Quinoxalinone Derivatives As Aldose Reductase Inhibitors

Synthesis and Structure-Activity Relationship Studies of Quinoxaline Derivatives as Aldose Reductase Inhibitors

An efficient synthesis of quinoxalinone derivatives as potent inhibitors of aldose reductase.

An Efficient Synthesis of Quinoxalinone Derivatives As Potent Inhibitors of Aldose Reductase

Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.

1,2-Benzothiazine 1,1-Dioxide Carboxylate Derivatives As Novel Potent Inhibitors of Aldose Reductase

A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity.

Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.

Study on Aldose Reductase Inhibitors Based on Quinoxalin Structure

Synthesis and structure–activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity

Design of Benzothiazolone‐Based Carboxylic Acid Aldose Reductase Inhibitors

Novel Synthesis of Nitro-Quinoxalinone Derivatives As Aldose Reductase Inhibitors

Multifunctional aldose reductase inhibitors based on 2H-benzothiazine 1,1-dioxide

Designing of Acyl Sulphonamide Based Quinoxalinones As Multifunctional Aldose Reductase Inhibitors.

Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity

Synthesis, Crystal Structures, Fluorescence and Xanthine Oxidase Inhibitory Activity of Pyrazole-Based 1,3,4-Oxadiazole Derivatives

Acetic Acid Derivatives of 3,4-Dihydro-2h-1,2,4-benzothiadiazine 1,1-Dioxide As a Novel Class of Potent Aldose Reductase Inhibitors.

Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1 H )-one as potent aldose reductase inhibitors with antioxidant activity

Identification of Quinoxalin-2(1H)-one Derivatives As a Novel Class of Multifunctional Aldose Reductase Inhibitors

Effect of C7 Modifications on Benzothiadiazine‐1,1‐dioxide Derivatives on Their Inhibitory Activity and Selectivity Toward Aldose Reductase

Synthesis, bioactivity and SAR study of N'-(5-substituted-1,3,4-thiadiazol-2-yl)-N-cyclopropylformyl-thioureas as ketol-acid reductoisomerase inhibitors.